Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company is seeking a Director, Global Competitive Intelligence to provide strategic and competitive insights to support decision-making and strategy-setting across various development programs.
Requirements
- Conducts thorough competitive and market assessments to identify market dynamics, trends, and potential impacts on Revolution Medicines’ pipeline, delivering insights to key stakeholders.
- Collaborates with stakeholders across the company (including Commercial, Medical Affairs, and R&D) to integrate internal and external information, analytics, and data.
- Maintains an in-depth understanding of Revolution Medicines’ diverse product offerings, competitive positioning, and the broader market dynamics shaping the industry's future.
- Benchmarks competitor clinical data, business models and capabilities.
- Translates insights into strategic recommendations to inform and influence decision making and strategy setting.
- Proactively facilitates the identification and prioritization of intelligence efforts critical to strategic planning and execution for key stakeholders; provides direction for the design and refinement of intelligence plans.
- Reinforces Competitive Intelligence best practices, identifies secondary data sources, vendor options, and methodologies that are best suited to address a business need. Manages third parties associated with this function.
- Participates in cross-functional teams to gather input for functional activities and to ensure alignment.
- Consistently and effectively communicates with key stakeholders in a timely manner to inform on critical updates.
Benefits
- Competitive cash compensation
- Robust equity awards
- Strong benefits
- Significant learning and development opportunities
